Since announcing her multiple sclerosis diagnosis in 2018, Selma Blair has been an outspoken advocate for people with MS. The ...

Disability worsens significantly faster after women with multiple sclerosis (MS) go through menopause, a new study shows.

PIPE-307 is a potentially first-in-class M1 receptor antagonist in development for patients with relapsing-remitting multiple sclerosis (RRMS). The Phase 2, randomized, double-blind, ...

Top-Line Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis Expected in April – – Reported Positive Outcome from Interim Analysis of Ongoing ...

Multiple sclerosis (MS) is a chronic condition affecting ... but some pharmaceutical and alternative treatments are available to help slow progression or treat the disease. Research is limited ...

Early signs and symptoms of multiple sclerosis (MS) can vary for each person. MS onset symptoms can include vision issues, weakness, tingling, numbness, and more. MS is a relapsing or progressive ...

Tolebrutinib is under clinical development by Sanofi and currently in Phase III for Secondary Progressive Multiple Sclerosis (SPMS). According to GlobalData, Phase III drugs for Secondary Progressive ...

They report a concerning relationship between micro and nanoplastic (MNP) concentrations in damaged tissues and links with multiple health conditions. Plastic usage soared from 1.5 million metric ...

All chronic liver diseases can lead to fibrosis and cirrhosis, but the progression timeline varies greatly from person to person. Some stay at the simple fatty liver stage, while others go through ...